摘要 |
Compounds of formula (I): (* CHEMICAL STRUCTURE *) (I) wherein R1, R2, R3, m, n, and R are as defined in the Specification. Medicinal products containing the same are useful in the treatment or prevention of thrombotic afflictions due to their thromboxane A2 receptor antagonistic activity and their thromboxane A2 synthase inhibitory activity. |